Skip to Page Content

FREE PREVIEW | Subscribers get full access to this article:   Free Trial »   Subscribe »

The Pink Sheet Daily

Molecular Dx Reimbursement: Medicare Contractor Seeks Tighter Controls


Executive Summary

West Coast contractor Palmetto issues draft proposal establishing a"non-coverage" policy for molecular tests not explicitly covered by Palmetto or a national CMS directive.


Purchase this Article

$35.00   Buy Now


For $35.00, purchase this 552-word article and receive immediate online access. 100% Satisfaction Guarantee.

View a complete sample article »

Already a Subscriber?

Log in for complete access.

Log In


Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.